After Consent Decree, Wockhardt May Sell US Site Amid Wider Revamp
Morton Grove Site Had Received Warning Letter Five Years Ago
Executive Summary
Wockhardt’s US arm Morton Grove Pharmaceuticals, which is bound by a consent decree of permanent injunction, discontinues production to undertake an “orderly closure” and potential sale of its Illinois site. Indian parent firm taps contract manufacturers to service US market.